1. Berenson GS, Srinivasan SR, Bao W, Newman WP, 3rd, Tracy RE, Wattigney WA: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338(23):1650-6.
2. DeBoer MD: Assessing and managing the metabolic syndrome in children and adolescents. Nutrients 2019, 11(8):1788.
3. Morrison JA, Friedman LA, Gray-McGuire C: Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007, 120(2):340-5.
4. Morrison JA, Friedman LA, Wang P, Glueck CJ: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 2008, 152(2):201-6.
5. Magnussen CG, Koskinen J, Chen W, Thomson R, Schmidt MD, Srinivasan SR, Kivimaki M, Mattsson N, Kahonen M, Laitinen T et al: Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation 2010, 122(16):1604-11.
6. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML, American Heart Association Atherosclerosis H, Obesity in the Young Committee of the Council on Cardiovascular Disease in the Y, Council on Cardiovascular N et al: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009, 119(4):628-47.
7. Martinez-Vizcaino V, Ortega FB, Solera-Martinez M, Ruiz JR, Labayen I, Eensoo D, Harro J, Loit HM, Veidebaum T, Sjostrom M: Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovasc Diabetol 2011, 10:81.
8. Goodman E, Daniels SR, Meigs JB, Dolan LM: Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007, 115(17):2316-22.
9. Stanley TL, Chen ML, Goodman E: The typology of metabolic syndrome in the transition to adulthood. J Clin Endocrinol Metab 2014, 99(3):1044-52.
10. Chan TF, Lin WT, Huang HL, Lee CY, Wu PW, Chiu YW, Huang CC, Tsai S, Lin CL, Lee CH: Consumption of sugar-sweetened beverages is associated with components of the metabolic syndrome in adolescents. Nutrients 2014, 6(5):2088-103.
11. Kim S, So WY: Prevalence of metabolic syndrome among Korean adolescents according to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation. Nutrients 2016, 8(10):588.
12. Song P, Yu J, Chang X, Wang M, An L: Prevalence and correlates of metabolic syndrome in Chinese children: The China Health and Nutrition Survey. Nutrients 2017, 9(1):79.
13. Gaston SA, Tulve NS, Ferguson TF: Abdominal obesity, metabolic dysfunction, and metabolic syndrome in U.S. adolescents: National Health and Nutrition Examination Survey 2011-2016. Ann Epidemiol 2019, 30:30-6.
14. Lin WT, Lee CY, Tsai S, Huang HL, Wu PW, Chin YT, Seal DW, Chen T, Chao YY, Lee CH: Clustering of metabolic risk components and associated lifestyle factors: A nationwide adolescent study in Taiwan. Nutrients 2019, 11(3):584.
15. Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Laing KY: Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 2006, 4(1):1-22.
16. The WHO STEPwise approach to noncommunicable disease risk factor surveillance. Section 4: Guide to Physical Measurements (Step 2). Availabale online: https://www.who.int/ncds/surveillance/steps/Section%204%20Step%202%20Physical%20Measurements.pdf (accessed on 17 Augest 2021). In.
17. Lin WT, Huang HL, Huang MC, Chan TF, Ciou SY, Lee CY, Chiu YW, Duh TH, Lin PL, Wang TN et al: Effects on uric acid, body mass index and blood pressure in adolescents of consuming beverages sweetened with high-fructose corn syrup. Int J Obes (Lond) 2013, 37(4):532-9.
18. Lin WT, Chan TF, Huang HL, Lee CY, Tsai S, Wu PW, Yang YC, Wang TN, Lee CH: Fructose-rich beverage intake and central adiposity, uric acid, and pediatric insulin resistance. J Pediatr 2016, 171:90-6 e1.
19. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20(4):470-5.
20. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S et al: The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007, 8(5):299-306.
21. The statement of Taiwan Pediatric Association for child and adolescent metabolic syndrome. Taiwan Pediatric Association, June 2016. Availabale online: https://www.pediatr.org.tw/people/edu_info.asp?id=33 (accessed on 17 Augest 2021).
22. Lin WT, Lin PC, Lee CY, Chen YL, Chan TF, Tsai S, Huang HL, Wu PW, Chin YT, Lin HY et al: Effects of insulin resistance on the association between the circulating retinol-binding protein 4 level and clustering of pediatric cardiometabolic risk factors. Pediatr Diabetes 2018, 19(4):611-21.
23. Wu PW, Tsai S, Lee CY, Lin WT, Chin YT, Huang HL, Seal DW, Chen T, Lee CH: Contribution of insulin resistance to the relationship between sugar-sweetened beverage intake and a constellation of cardiometabolic abnormalities in adolescents. Int J Obes (Lond) 2021, 45(4):828-39.
24. Altman DG: Practical statistics for medical research. London, UK: Chapman and Hall; 1991.
25. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-74.
26. Rothman K, Greenland S: Modern epidemiology, 2nd edition edn. Philadelphia: Lippincott Williams & Wilkins; 1998.
27. Lee CH, Lee KW, Fang FM, Wu DC, Tsai SM, Chen PH, Shieh TY, Chen CH, Wu IC, Huang HL et al: The neoplastic impact of tobacco-free betel-quid on the histological type and the anatomical site of aerodigestive tract cancers. Int J Cancer 2012, 131(5):E733-43.
28. Shulman GI: Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014, 371(23):2237-8.
29. DeBoer MD, Gurka MJ, Woo JG, Morrison JA: Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study. Diabetologia 2015, 58(12):2745-52.
30. Gurka MJ, Golden SH, Musani SK, Sims M, Vishnu A, Guo Y, Cardel M, Pearson TA, DeBoer MD: Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia 2017, 60(7):1261-70.
31. DeBoer MD, Filipp SL, Sims M, Musani SK, Gurka MJ: Risk of ischemic stroke increases over the spectrum of metabolic syndrome severity. Stroke 2020, 51(8):2548-52.
32. Magnussen CG, Koskinen J, Juonala M, Chen W, Srinivasan SR, Sabin MA, Thomson R, Schmidt MD, Nguyen QM, Xu JH et al: A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa heart and cardiovascular risk in young Finns studies. J Am Coll Cardiol 2012, 60(17):1631-9.
33. Huh JH, Ahn SG, Kim YI, Go T, Sung KC, Choi JH, Koh KK, Kim JY: Impact of longitudinal changes in metabolic syndrome status over 2 years on 10-year incident diabetes mellitus. Diabetes Metab J 2019, 43(4):530-8.
34. Itoh H, Kurihara I, Miyashita K, Tanaka M: Clinical significance of 'cardiometabolic memory': a systematic review of randomized controlled trials. Hypertens Res 2017, 40(6):526-34.